The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) solicits applications to establish a Coordination and Data Sharing Center (CDSC) in support of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers. Together, the CDSC and ReVAMPP Centers will form the ReVAMPP Network. The purpose of the CDSC is to support, coordinate, and manage ongoing and planned activities within the ReVAMPP Network. The CDSC is expected to establish and maintain a collaborative ReVAMPP Network platform for data sharing and dissemination as needed to harmonize reagents, assays, animal models and exchange knowledge on structure/function-based vaccine solutions and antigen/immunogen design as well as assess the utility of vaccine technology platforms for virus families studied under the ReVAMPP Centers. The CDSC is also expected to facilitate effective communications across the ReVAMPP Centers by scheduling, and managing all meetings, tracking overall network progress and outputs, developing opportunities for collaboration among the Centers such as establishing working groups, and collating information and facilitating exchange with other NIAID/NIH programs, U.S. Government (USG) partners, and other key stakeholders, including the World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), and Coalition for Epidemic Preparedness Innovations (CEPI) among others as appropriate.
The ReVAMMP Centers, supported by separate companion NOFOs (RFA-AI-23-019 and RFA-AI-23-020), will consist of multi-project cooperative agreements that establish comprehensive, cooperative basic, and translational research Centers to carry out in-depth research on prototype members of select virus families that have the potential to emerge as pandemic pathogens. Together the CDSC and ReVAMPP Centers will form the ReVAMPP Network. This new Network will align with the goals of the American Pandemic Preparedness Plan: Transforming Our Capabilities (AP3), which was announced in September 2021, and recognizes the need for a trans-government investment and response to combat future pandemics and NIAID's Pandemic Preparedness Plan.
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date: June 8, 2023
RFA-AI-23-021 Expiration Date June 09, 2023
Applicants to this NOFO will not be eligible to submit to or participate in the companion ReVAMPP Centers NOFOs (RFA-AI-23-019 and RFA-AI-23-020) because of the unique, centralized role of the CDSC in ReVAMPP Network coordination and communication.
Application budgets are not expected to exceed $1.5M in direct costs per year and need to reflect the actual needs of the proposed project.
The project period is 5 years.